Key result
P-wave dispersion 3 years post-percutaneous mitral balloon valvuloplasty independently predicted a composite of restenosis, AF, and redo valvuloplasty (HR 1.36; 95% CI 1.002-1.867; p=0.048).
Why the study?
The study aimed to investigate the immediate and long-term effects of successful PMBV on PWD in patients with severe rheumatic MS and to evaluate restenosis, AF, and redo balloon valvuloplasty rates.
Cohort (n=41)
Hazard Ratio: 1.36 (95% CI 1.002–1.867)
p-value: p=0.048
P-wave dispersion decreases immediately after percutaneous mitral balloon valvuloplasty, and its long-term measurement is an independent predictor of adverse clinical outcomes including atrial fibrillation and restenosis.
BACKGROUND: P-wave dispersion (PWD) is an electrocardiographic (ECG) marker of nonuniform and heterogeneous atrial conduction with ECG leads of different orientation. The aim of our study was to investigate the immediate and long term effects of successful percutaneous mitral balloon valvuloplasty (PMBV) on PWD in severe rheumatic MS patients and to analyse the restenosis, atrial fibrillation (AF) and redo balloon valvuloplasty rate. METHODS: We enrolled 41 consecutive MS patients with sinus rhythm who underwent PMBV. A 12-lead ECG and transthoracic echocardiography were performed for each patient one day before, within 72 hours after the procedure and followed up by clinical visit at a mean of 5,57±1,46 (3-8) year.The mean patient age was 44.1±10.86 years. RESULTS: Pmax 1(pre PMBV) and PWD 1(pre PMBV) decreased 1-3 days after PMBV. MVA improved immediately after the procedure; but lately the mean MVA decreased significantly indicating the initiation of restenosis. Composite endpoints were associated with LA 1 (p = 0.02), MVA 2 (1-3 days after PMBV) (p= 0.019), mean gradient 2 (p= 0.028), PWD 3 (3 years after PMBV) (p < 0.001) and Pmax 3 (3 years after PMBV) (<0,001). AF incidence was associated with PWD 2 (p=0,019) and PWD 3 (p=0,010). There was 14 composite endpoint on follow up and at multivariate analysis PWD 3 was identified as an independent predictor of the composite endpoint (p=0.048, hazard ratio=1.36, 95% confidence interval (CI): 1,002-1.867). CONCLUSIONS: This study has demonstrated that Pmax and PWD significantly decreased within 3 days after PMBV. Furthermore, long term PWD was associated with AF and identified as an independent predictor of the composite endpoint.
No takes yet. Share an insight, caveat, or question.
Zencirkiran Agus Hicaz (2019) conducted a cohort in Severe rheumatic mitral stenosis (n=41). Percutaneous mitral balloon valvuloplasty (PMBV) was evaluated on Composite endpoint (restenosis, atrial fibrillation, and redo balloon valvuloplasty) (HR 1.36, 95% CI 1.002-1.867, p=0.048). P-wave dispersion 3 years post-percutaneous mitral balloon valvuloplasty independently predicted a composite of restenosis, AF, and redo valvuloplasty (HR 1.36; 95% CI 1.002-1.867; p=0.048).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: